(5) |
Based on a Schedule 13D filed by Cyrus Capital Partners, L.P., a Delaware limited partnership (“Cyrus Capital Partners”), Cyrus Capital Partners GP, L.L.C., a Delaware limited liability company (“Cyrus Capital GP”), Cyrus Capital Advisors, L.L.C., a Delaware limited liability company (“Cyrus Capital Advisors”) and Mr. Stephen C. Freidheim on May 10, 2021. These securities are beneficially owned by (i) Canary SC Master Fund, L.P., a Delaware limited partnership (“CANM”), as a result of its direct ownership of 1,603,445 shares of common stock and 3,604,095 shares of Series A preferred stock, (ii) Crescent 1, L.P., a Delaware limited partnership (“CRES”), as a result of its direct ownership of 2,095,093 shares of common stock and 4,709,181 shares of Series A preferred stock, (iii) CRS Master Fund, L.P., a Delaware limited partnership (“CRSM”), as a result of its direct ownership of 1,994,954 shares of common stock and 4,484,097 shares of Series A preferred stock, (iv) Cyrus 1740 Master Fund, L.P., a Delaware limited partnership (“C1740M”), as a result of its direct ownership of 264,724 shares of common stock and 595,025 shares of Series A preferred stock, (v) Cyrus Opportunities Master Fund II, Ltd., a Delaware limited partnership (“COFII”), as a result of its direct ownership of 3,593,111 shares of common stock and 8,076,306 shares of Series A preferred stock, (vi) Cyrus Select Opportunities Master Fund II, L.P., a Delaware limited partnership (“CSOM2”), as a result of its direct ownership of 41,955 shares of common stock and 94,303 shares of Series A preferred stock, (vii) Cyrus Select Opportunities Master Fund, Ltd, a Delaware limited partnership (“CSOM”), as a result of its direct ownership of 617,127 shares of common stock and 1,387,128 shares of Series A preferred stock, (viii) PC Investors III, L.P., a Delaware limited partnership (“PCI3”), as a result of its direct ownership of 8,170 shares of common stock and 18,364 shares of Series A preferred stock, and (ix) Peterson Capital Investors, LLC, a Delaware limited liability company (“PCIN”), as a result of its direct ownership of 1,675 shares of common stock and 3,765 shares of Series A preferred stock. Cyrus Capital Partners is the investment manager of certain private funds and managed accounts that directly hold shares of common stock and Series A preferred stock, including CANM, CRES, CRSM, C1740M, COFII, CSOM2, CSOM, PCI3 and PCIN. Cyrus Capital Advisors is the general partner of CANM, CRES, CRSM, C1740M and CSOM2. Cyrus Capital GP is the general partner of Cyrus Capital Partners and the managing member of Cyrus Capital Advisors. Mr. Stephen C. Freidheim, as the Chief Investment Officer of Cyrus Capital Partners and the sole member and manager of Cyrus Capital GP. Accordingly, Cyrus Capital Advisors reports having sole voting and dispositive power over 6,000,171 shares of Common Stock and 13,486,701 shares of Series A preferred stock, and each of Cyrus Capital Partners, Cyrus Capital GP and Mr. Freidheim report having sole voting and dispositive power over 10,220,254 shares of Common Stock and 22,972,264 shares of Series A preferred stock. The address of each of the foregoing is 65 East 55th Street, 35th Floor, New York, New York, 10022. |